Tweet
Ther Adv Chronic Dis
. 2022 May 20;13:20406223221099333.
doi: 10.1177/20406223221099333. eCollection 2022.
COVID-19-induced psoriatic arthritis: a case report
Francis Essien 1 , Lisa Chastant 2 , Collen McNulty 3 , Matthew Hubbard 4 , Luria Lynette 5 , Matthew Carroll 6
Affiliations
- PMID: 35620185
- PMCID: PMC9128051
- DOI: 10.1177/20406223221099333
Abstract
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which may lead to uncontrolled immune activation and cytokine response in some. The pattern of pro-inflammatory cytokines is similar to that which has been observed to be involved in rheumatic diseases and target treatments. Viral arthritis is common with a wide variety in spectrum ranging from arthralgia to spurious and chronic arthritis. However, recent studies have demonstrated a correlation with endemic coronaviruses and increased risk of developing rheumatoid arthritis (RA). Cases are being identified that describe a post-COVID reactive; however, to date, no report has been published describing the onset of psoriasis and concomitant development of psoriatic arthritis after COVID-19 infection. We report an interesting case of psoriatic arthritis in a post-COVID-19 infection patient with review of the current literature.
Keywords: COVID-19; TNF-alpha inhibitors; autoimmune disease; psoriasis; viral-induced arthropathy.